Latest Articles

Publication Date
The Role and Mechanism of Incretins in Gynaecologic Diseases.

Obesity is a major global public health concern closely linked to the development and progression of various gynaecological disorders, particularly polycystic ovary syndrome (PCOS) and endometrial cancer. Incretins, a group …

Published: Sept. 26, 2026, midnight
Mayo Clinic Minute: Fertility-sparing treatment of endometrial cancer (VIDEO) - Mayo Clinic News Network

Mayo Clinic Minute: Fertility-sparing treatment of endometrial cancer (VIDEO) Mayo Clinic News Network

Published: Sept. 24, 2026, 1:33 p.m.
Mayo Clinic Minute: Fertility-sparing treatment of endometrial cancer (VIDEO) - newsnetwork.mayoclinic.org

Mayo Clinic Minute: Fertility-sparing treatment of endometrial cancer (VIDEO) newsnetwork.mayoclinic.org

Published: Sept. 24, 2026, 1:33 p.m.
Fgl-1 Emerges as an Oncogenic Driver Fueling Endometrial Cancer Through PI3K/AKT Signaling - Bioengineer.org

Fgl-1 Emerges as an Oncogenic Driver Fueling Endometrial Cancer Through PI3K/AKT Signaling Bioengineer.org

Published: Sept. 23, 2026, 1:24 a.m.
Fgl-1 Emerges as an Oncogenic Driver Fueling Endometrial Cancer Through PI3K/AKT Signaling - bioengineer.org

Fgl-1 Emerges as an Oncogenic Driver Fueling Endometrial Cancer Through PI3K/AKT Signaling bioengineer.org

Published: Sept. 23, 2026, 1:24 a.m.
Canada’s first-ever endometrial cancer awareness week - CTV News

Canada’s first-ever endometrial cancer awareness week CTV News

Published: Sept. 22, 2026, 2:27 p.m.
Canada’s first-ever endometrial cancer awareness week - ctvnews.ca

Canada’s first-ever endometrial cancer awareness week ctvnews.ca

Published: Sept. 22, 2026, 2:27 p.m.
Endometrial Cancer Pipeline Insight 2026: 50+ Companies - openPR.com

Endometrial Cancer Pipeline Insight 2026: 50+ Companies openPR.com

Published: Sept. 21, 2026, 12:52 p.m.
Endometrial Cancer Pipeline Insight 2026: 50+ Companies - openpr.com

Endometrial Cancer Pipeline Insight 2026: 50+ Companies openpr.com

Published: Sept. 21, 2026, 12:52 p.m.
Cholesterol Enzyme DHCR24 Emerges as Driver and Biomarker of Endometrial Cancer - Bioengineer.org

Cholesterol Enzyme DHCR24 Emerges as Driver and Biomarker of Endometrial Cancer Bioengineer.org

Published: Sept. 20, 2026, 11:23 p.m.
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!